$MEDP insider trading
Over the last 12 months, Medpace Holdings insiders reported no purchases and 34 sales totaling $356.5M across SEC Form 4 filings. 3% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $356.5M 34 events
- Events · 12m
- 34 Form 4 filings, grouped
- Insiders · 12m
- 9 distinct reporters
- 10b5-1 share
- 3% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 24,741 | $621 | $15.4M | -4.6% | 2 tranches |
| Aug 27, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 650 | $620.27 | $403K | -0.1% | — |
| Aug 26, 2026 | Kraft Robert O.D | ▼ Sale | 3,858 | $617.81 | $2.4M | -80.2% | — |
| Aug 26, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 4,673 | $620.08 | $2.9M | -0.9% | 2 tranches |
| Aug 24, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 15,978 | $623.93 | $10.0M | -2.8% | 2 tranches |
| Aug 20, 2026 | Brady Kevin M.CFO & Treasurer · O | ▼ Sale | 3,400 | $625.24 | $2.1M | -20.9% | — |
| Aug 20, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 42,783 | $614.3 | $26.3M | -7.1% | 2 tranches |
| Aug 19, 2026 | Carley Brian TD | ▼ Sale | 5,000 | $608.63 | $3.0M | -15.2% | — |
| Aug 19, 2026 | DAVENPORT FRED B JRD | ▼ Sale | 7,283 | $606.15 | $4.4M | -65.7% | — |
| Aug 13, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 11,824 | $601.49 | $7.1M | -1.9% | 2 tranches |
| Aug 11, 2026 | McCarthy Cornelius P. IIID | ▼ Sale | 1,140 | $605.37 | $690K | -8.5% | — |
| Aug 11, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 23,144 | $604.25 | $14.0M | -3.6% | 2 tranches |
| Aug 7, 2026 | McCarthy Cornelius P. IIID | ▼ Sale | 795 | $585.07 | $465K | -5.6% | — |
| Jul 28, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 7,238 | $600.44 | $4.3M | -1.1% | 2 tranches |
| Jul 28, 2026 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 7,500 | $600 | $4.5M | -10.6% | — |
| May 28, 2026 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. · O | ▼ Sale | 16,349 | $450 | $7.4M | -44.6% | — |
| Mar 17, 2026 | GEIGER JESSE JPresident · O | ▼ Sale | 31,707 | $455.3 | $14.4M | -67.9% | — |
| Dec 3, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 668 | $590.69 | $395K | -0.1% | — |
| Dec 2, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 28,876 | $592.7 | $17.1M | -4.3% | 2 tranches |
| Nov 28, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 56,482 | $603.28 | $34.1M | -7.7% | 2 tranches |
| Nov 25, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 101,417 | $611.02 | $62.0M | -12.2% | 2 tranches |
| Nov 24, 2025 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 20,000 | $609.15 | $12.2M | -42.1% | — |
| Nov 21, 2025 | Brady Kevin M.CFO & Treasurer · O | ▼ Sale | 3,000 | $590.35 | $1.8M | -33.3% | — |
| Nov 21, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 28,688 | $593.68 | $17.0M | -3.3% | 2 tranches |
| Nov 19, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 31,053 | $591.79 | $18.4M | -3.5% | 2 tranches |
| Nov 17, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 20,794 | $594.02 | $12.4M | -2.3% | 2 tranches |
| Nov 14, 2025 | Kraft Robert O.D | ▼ Sale | 6,472 | $591.85 | $3.8M | -88.6% | — |
| Nov 13, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 10,440 | $602.32 | $6.3M | -1.1% | 2 tranches |
| Nov 11, 2025 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 18,000 | $605 | $10.9M | -27.5% | — |
| Nov 5, 2025 | GEIGER JESSE JPresident · O | ▼ Sale | 21,503 | $595.66 | $12.8M | -58.9% | plan |
| Oct 30, 2025 | DAVENPORT FRED B JRD | ▼ Sale | 5,972 | $581.88 | $3.5M | -63.1% | — |
| Oct 29, 2025 | GEIGER JESSE JPresident · O | ▼ Sale | 23,028 | $602 | $13.9M | -38.7% | 2 tranches |
| Oct 27, 2025 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 2,000 | $605.01 | $1.2M | -3% | — |
| Oct 27, 2025 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. · O | ▼ Sale | 15,230 | $598.85 | $9.1M | -53.3% | — |
| Sep 3, 2025 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 10,000 | $480 | $4.8M | -14.8% | — |
| Sep 2, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 37,393 | $475.87 | $17.8M | -3.9% | 2 tranches |
| Aug 27, 2025 | Troendle August J.CEO · O·D·10% | ▼ Sale | 620 | $475 | $295K | -0.1% | — |
| Aug 19, 2025 | McCarthy Cornelius P. IIID | ▼ Sale | 1,662 | $465.04 | $773K | -14% | — |
Every $MEDP filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Medpace Holdings filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MEDP feed.